Have there been any azithromycin deaths?

The New England Journal of Medicine (NEJM) study of azithromycin cites deaths among users of the drug, but to maintain technical accuracy considers additional factors, such as the prior existence of heart disease among deceased patients in the study.

Researchers concluded that azithromycin was associated with an increased risk of cardiovascular death and with death from any cause, with an estimated 47 additional cardiovascular deaths per 1 million courses of azithromycin. In the study’s conclusion, researchers wrote, “During 5 days of azithromycin therapy, there was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease.”